Cite
HARVARD Citation
Gressens, S. et al. (2022). Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies. Clinical microbiology and infection. pp. 885.e7-885.e11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gressens, S. et al. (2022). Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies. Clinical microbiology and infection. pp. 885.e7-885.e11. [Online].